StackTerminal.Health

BETA

Joint Pain & Inflammation Relief

Public 06 Apr 2026

Devil's claw & white willow bark are combined to relieve joint pain & reduce inflammation. Devil's claw is known for its anti-inflammatory properties, while white willow bark provides natural pain relief.

Joint Pain & Inflammation Relief
Devil's Claw
Daily with food
MODERATE
2400mg
White Willow Bark
Daily with food
MODERATE
240mg
No interactions detected
Each dose includes evidence rationale · doses personalized to your weight
AI risk assessment
Context: No wearable data
PROAI risk assessment is available with Pro.
See plans
Stack pre-check
No personal data connected — connect wearables or upload bloodwork for a personalised check
Clean
Supplements
2
Training load
Unknown
No flags
No duplication, stimulant, interaction, or recovery concerns detected.

Pre-check is rule-based, not medical advice. Consult a healthcare professional for personalised guidance.

Interaction Analysis
Pharmacokinetic + pair-level checks
Timing optimizations
White Willow Bark
Take ~1.5h before the intended effect window
Reaches peak plasma concentration in ~1.5h. Half-life ~2.5h.

Interaction analysis is based on peer-reviewed pharmacology. PMID links go to PubMed. Not medical advice.

Supplements
2 items
Devil's ClawModerate
Daily with food
Provides anti-inflammatory support for joint pain relief.
2400mg
Osteoarthritis pain reduction
Moderate
Population: Patients with osteoarthritis
Study type: Systematic review
Dose context: 2400 mg typical

Devil's Claw may be a safer treatment option for osteoarthritis compared to NSAIDs.

Citation: Brien et al. (2006). Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety. Journal of Alternative and Complementary Medicine.DOI: 10.1089/acm.2006.12.981
Low back pain reduction
Moderate
Population: Adults with low back pain
Study type: Cochrane review
Dose context: 2400 mg typical

Devil's Claw appeared effective in reducing pain symptoms in low back pain.

Citation: Gagnier et al. (2016). Herbal Medicine for Low Back Pain: A Cochrane Review. Spine.DOI: 10.1097/BRS.0000000000001310
Further long-term assessment is required.
Safety profile
Low
Population: General population using Devil's Claw
Study type: Systematic review
Dose context: 2400 mg typical

Devil's Claw is associated with a minor risk relative to NSAIDs.

Citation: Brendler et al. (2013). Devil's claw root: ulcers and gastrointestinal bleeding? Spine.DOI: 10.1097/01.brs.0000249525.70011.fe
Further clinical investigations are warranted.
Daily with food
Offers natural pain relief for joint discomfort.
240mg
Pain reduction in low back pain
Moderate
Population: Adults with chronic non-specific low back pain
Study type: Systematic review
Dose context: 400 mg typical

Herbal medicines, including white willow bark, are used for treating low back pain, but evidence quality varies.

Citation: Oltean et al. (2014). Herbal medicine for low-back pain. Cochrane Database of Systematic Reviews.DOI: 10.1002/14651858.CD004504.pub4
Part of a broader review on herbal treatments for low back pain.
Joint pain alleviation
Moderate
Population: Community adults with joint pain
Study type: RCT
Dose context: 400 mg typical

White willow bark, among other herbs, showed moderate quality evidence for pain reduction.

Citation: Nieman et al. (2013). A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial.DOI: 10.15585/mmwr.mm6736a2
Part of a study on various herbal supplements.
Pain reduction in low back pain
Moderate
Population: Adults with acute, sub-acute, or chronic non-specific low back pain
Study type: Cochrane review
Dose context: 400 mg typical

RCTs included in the review suggest herbal medicines can reduce pain & improve function.

Citation: Gagnier et al. (2007). Herbal medicine for low back pain: a Cochrane review. Spine.DOI: 10.1097/01.brs.0000249525.70011.fe
Focus on various herbal interventions including white willow bark.
My experience with this stack
Share what worked, what did not, & help improve this protocol.

Discussion

No comments yet. Be the first to add context or ask a question.
Max 500 characters

Similar community stacks

Avoid reinventing the wheel: fork a community stack that matches your category tags, then edit it.

Browse all community stacks →
recoverypeptidestissue-repair

BPC-157 & TB-500 are the two most researched recovery peptides, with complementary mechanisms. BPC-157 (Body Protection Compound) accelerates tendon, ligament, & gut repair via angiogenesis & growth factor upregulation. TB-500 (Thymosin Beta-4) promotes systemic tissue repair, reduces inflammation, & improves mobility. GHK-Cu supports collagen synthesis & skin regeneration. Note: all three are research compounds not approved for human therapeutic use.

BPC-157
0mg
TB500 (TB4 / Thymosin Beta-4)
5mg
GHK-Cu
1mg
New
View